Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ...
In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli Lilly’s partnership with Walmart to launch retail pickup for its ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now. As of the close of business on December 17, Wall Street analysts have a consensus Strong Buy rating on the ...
Why You Should Watch Alexion Pharmaceuticals, Inc., Ariad Pharmaceuticals and Thermo Fisher Scientif
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Good morning, ...
STOCKHOLM, Sept. 13, 2023 /PRNewswire/ -- Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services. The goal is to partner with pharmaceutical ...
* THERMO FISHER - AGREEMENT WITH AGIOS CALLS FOR IDENTIFYING IDH GENE MUTATIONS USING ONCOMINE PRECISION ASSAY AND ION TORRENT GENEXUS SYSTEM * THERMO FISHER SCIENTIFIC INC - WILL RETAIN RIGHTS TO ...
SAN MATEO, Calif. and SINGAPORE, Jan. 03, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (APRTF) (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative ...
Thermo Fisher Scientific Inc., has announced a cooperation agreement with Agere Pharmaceuticals Inc., which will enable customers to accelerate formulation development of pharmaceutical compounds. The ...
The collaboration will leverage Thermo Fisher’s Accelerator Drug Development stable of solutions, which was launched in the fall of 2024. Lyndra Therapeutics, of Watertown, Mass., announced on Jan. 15 ...
* Thermo Fisher Scientific Co will retain rights to commercialize test globally and will lead necessary filings to seek clearance from regional regulatory agencies * Says under terms of agreement, ...
Why You Should Watch Alexion Pharmaceuticals, Inc., Ariad Pharmaceuticals and Thermo Fisher Scientif
Good morning, fellow Foolish investors! It's time to check in on today's movers in health care. Alexion Pharmaceuticals beats earnings estimates First up is Alexion Pharmaceuticals which is moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback